Skip to main content

PCSA

Stock
Health Care
Biotechnology

Performance overview

PCSA Price
Price Chart

Forward-looking statistics

Beta
0.51
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.

Company info

SectorHealth Care
IndustryBiotechnology
Employees13
Market cap$4.7M

Fundamentals

Enterprise value-$411.1K
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity1.41

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.06
Dividend per share
Revenue per share
Avg trading volume (30 day)$7M
Avg trading volume (10 day)$5M
Put-call ratio

Macro factor sensitivity

Growth-3.2
Credit+7.9
Liquidity+0.7
Inflation-7.5
Commodities+0.0
Interest Rates+0.9

Valuation

Dividend yield0.00%
PEG Ratio-0.09
Price to sales
P/E Ratio-0.09
Enterprise Value to Revenue
Price to book0.29

Upcoming events

Next earnings dayMay 9, 2025
Next dividend day
Ex. dividend day

News

Heatwurx Inc. (PCSA) Upgraded to Buy: Here's What You Should Know

Heatwurx Inc. (PCSA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (April 6, 2023)
Processa Pharmaceuticals In-Licenses Ocuphire's Anticancer Agent

Processa Pharmaceuticals Inc (NASDAQ: PCSA) has entered into a licensing agreement with Ocuphire Pharma Inc (NASDAQ: OCUP) to in-license RX-3117. RX-3117 is an oral anticancer agent with an improved pharmacological profile relative to gemcitabine and other nucleoside analogs.

Benzinga (June 17, 2021)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free